Daria O’Reilly, PhD, MSc

Lead Health Economist, Pharmacy Consulting, Health Benefits Management

TELUS Health and Associate Professor (PT), Department of Health Research Methods, Evidence, and Impact, McMaster University

Daria holds a Master’s and PhD in Clinical Epidemiology and a post-doctoral fellowship in pharmacoeconomics. Dr. O’Reilly became an Associate Professor, Department of Health Research Methods, Evidence and Impact, McMaster University in 2007 and continues to hold a part-time appointment. Over the past two decades, Daria has worked in the area of Health Technology Assessment for the government and the pharmaceutical industry to develop evidence to support informed healthcare policy decision making. She has authored two book chapters and more than 100 scientific papers. Daria joined the TELUS Health team September 2018 as Lead Health Economist. Her priority is reviewing the economic evidence of drugs submitted for formulary listing, ensuring the results are relevant to the private payer, and providing recommendations to help make evidence-informed reimbursement decisions based on cost effectiveness.

All Sessions by Daria O’Reilly, PhD, MSc

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

3:15 pm

3:15 pm


Pathways to Access & Reimbursement for Private Payers

Continued tightening of access to private payer formularies combined with a move to outsource benefit plans and administration to third parties for some payers, means an increase in barriers to listings. Benefit plans are the pathway to accessing medications for almost two thirds of Canadians:
·        Understand TELUS Health’s review process for managed formularies.
·        Learn how pharma companies can better align their submissions to private payor needs.
·        Gain insight into private group insurance plans and current trends

Learn about important processes being used to gain drug listing and understand how the private payer market in Canada is evolving. 

Agenda: Day 2 Oct 6, 2020